HARVEY MICHAEL FRIEDMAN
Medical Practice in Merion Station, PA
License number
Pennsylvania MD014810E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Merion Station, PA 19066
Personal information
See more information about HARVEY MICHAEL FRIEDMAN at radaris.comName
Address
Phone
5600 Munhall Rd APT 904, Pittsburgh, PA 15217
3200 Bensalem Blvd APT M104, Bensalem, PA 19020
194 Linden Dr, Elkins Park, PA 19027
310 Winding Way, Merion Station, PA 19066
194 Linden Ave, Glenside, PA 19038
Professional information
Compositions And Methods Useful In Treatment And Prevention Of Hiv-1 Infection
US Patent:
6287605, Sep 11, 2001
Filed:
Apr 16, 1999
Appl. No.:
9/293758
Inventors:
Daniel Malamud - Merion PA
Thandavarayan Nagashunmugam - Havertown PA
Harvey M. Friedman - Merion PA
William Abrams - Merion PA
Earl J. Bergey - South Dayton NY
Thandavarayan Nagashunmugam - Havertown PA
Harvey M. Friedman - Merion PA
William Abrams - Merion PA
Earl J. Bergey - South Dayton NY
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61K 3537
US Classification:
424550
Abstract:
The invention includes compositions comprising substantially purified salivary glycoproteins and carbohydrate ligands thereof which are useful in methods for the treatment and prevention of HIV-1 infection. The invention also includes methods for the treatment and prevention of HIV-1 infection comprising contacting a composition of the invention with a human patient. Additionally, the invention includes antibodies and kits useful in the treatment and prevention of HIV-1 infection.
Herpes Simplex Virus Combined Subunit Vaccines And Methods Of Use Thereof
US Patent:
8057804, Nov 15, 2011
Filed:
Jul 24, 2008
Appl. No.:
12/179439
Inventors:
Harvey Friedman - Merion PA, US
Sita Awasthi - Bala Cynwyd PA, US
John Lubinski - Malvern PA, US
Sita Awasthi - Bala Cynwyd PA, US
John Lubinski - Malvern PA, US
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61K 39/245
US Classification:
4242311
Abstract:
This invention provides vaccines comprising two or more recombinant Herpes Simplex Virus (HSV) proteins selected from a gD protein, a gC protein and a gE protein; and methods of impeding immune evasion by HSV thereby vaccinating a subject against HSV and treating, suppressing, inhibiting, and/or reducing an incidence of an HSV infection or a symptom or manifestation thereof, comprising administration of a vaccine of the present invention.
Herpes Simplex Virus Combined Subunit Vaccines And Methods Of Use Thereof
US Patent:
2013002, Jan 31, 2013
Filed:
Jun 4, 2012
Appl. No.:
13/487966
Inventors:
Harvey FRIEDMAN - Merion PA, US
Sita Awasthi - Bala Cynwyd PA, US
John Lubinski - Malvern PA, US
Sita Awasthi - Bala Cynwyd PA, US
John Lubinski - Malvern PA, US
International Classification:
A61K 39/245, A61P 31/22
US Classification:
4241861
Abstract:
This invention provides immunogenic compositions comprising two or three recombinant Herpes Simplex Virus (HSV) proteins selected from a gD protein, a gC protein and a gE protein; and methods of impeding immune evasion by HSV, inducing an anti-HSV immune response, and treating, suppressing, inhibiting, and/or reducing an incidence of an HSV infection or a symptom or manifestation thereof, comprising administration of a vaccine of the present invention.
Hsv-1 And Hsv-2 Vaccines And Methods Of Use Thereof
US Patent:
2012011, May 10, 2012
Filed:
Mar 31, 2010
Appl. No.:
13/260835
Inventors:
Harvey M. Friedman - Merion PA, US
Elizabeth E. Brittle - Middletown MD, US
Fushan Wang - Broomall PA, US
Elizabeth E. Brittle - Middletown MD, US
Fushan Wang - Broomall PA, US
International Classification:
A61K 39/245, A61P 31/22
US Classification:
4242311
Abstract:
This invention provides methods of treating, suppressing, inhibiting, reducing an incidence, reducing the pathogenesis of, ameliorating the symptoms of, or ameliorating the secondary symptoms of a primary or recurring Herpes Simplex Virus (HSV) infection, or prolonging the latency to a relapse of an HSV infection, and disorders and symptoms associated with same and inducing an anti-HSV immune response in a subject comprising the step of contacting the subject with a composition comprising a mutant HSV strain comprising an inactivating mutation in a Us8 gene, followed by a second contacting with the composition.
Herpes Simplex Virus Combined Subunit Vaccines And Methods Of Use Thereof
US Patent:
2011025, Oct 20, 2011
Filed:
Nov 13, 2008
Appl. No.:
12/270772
Inventors:
Harvey FRIEDMAN - Merion PA, US
Sita AWASTHI - Bala Cynwyd PA, US
John LUBINSKI - Malvern PA, US
Sita AWASTHI - Bala Cynwyd PA, US
John LUBINSKI - Malvern PA, US
International Classification:
A61K 39/245, A61P 31/22, A61P 37/04
US Classification:
4242311
Abstract:
This invention provides vaccines comprising two or more recombinant Herpes Simplex Virus (HSV) proteins selected from a gD protein, a gC protein and a gE protein; and methods of impeding immune evasion by HSV thereby vaccinating a subject against HSV and treating, suppressing, inhibiting, and/or reducing an incidence of an an HSV infection or a symptom or manifestation thereof, comprising administration of a vaccine of the present invention.
Hsv-1 And Hsv-2 Vaccines And Methods Of Use Thereof
US Patent:
2011017, Jul 21, 2011
Filed:
Sep 7, 2007
Appl. No.:
12/440223
Inventors:
Harvey Friedman - Merion PA, US
Elizabeth E. Zumbrun - Middletown MD, US
Fushan Wang - Broomall PA, US
Elizabeth E. Zumbrun - Middletown MD, US
Fushan Wang - Broomall PA, US
International Classification:
A61K 39/245, C12N 7/04, A61P 31/22
US Classification:
4242311, 435236
Abstract:
This invention provides methods of vaccinating a subject against a Herpes Simplex Virus (HSV) infection and disorders and symptoms associated with same, and impeding, inhibiting, reducing the incidence of, and suppressing HSV infection, neuronal viral spread, formation of zosteriform lesions, herpetic ocular disease, herpes-mediated encephalitis, and genital ulcer disease in a subject, comprising the step of contacting the subject with a mutant strain of the HSV, containing an inactivating mutation in a gene encoding a gE, gl, Us9, or other proteins.
Methods Of Use For Hsv-1 And Hsv-2 Vaccines
US Patent:
2009024, Oct 1, 2009
Filed:
Mar 31, 2009
Appl. No.:
12/415152
Inventors:
Harvey FRIEDMAN - Merion PA, US
Elizabeth E. ZUMBRUN - Middletown MD, US
Elizabeth E. ZUMBRUN - Middletown MD, US
International Classification:
A61K 39/245, A61P 31/22
US Classification:
4242311
Abstract:
This invention provides methods of treating, suppressing, inhibiting, reducing an incidence, reducing the pathogenesis of, ameliorating the symptoms of, or ameliorating the secondary symptoms of a primary or recurring Herpes Simplex Virus (HSV) infection, or prolonging the latency to a relapse of an HSV infection, and disorders and symptoms associated with same and inducing an anti-HSV immune response in a subject comprising the step of contacting the subject with a composition comprising a mutant HSV strain comprising an inactivating mutation in a Us8 gene, followed by a second contacting with the composition.
Herpes Simplex Virus Combined Subunit Vaccines And Methods Of Use Thereof
US Patent:
2009009, Apr 16, 2009
Filed:
Dec 27, 2007
Appl. No.:
12/005407
Inventors:
Harvey Friedman - Merion PA, US
Sita Awasthi - Bala Cynwid PA, US
John Lubinski - Malvern PA, US
Sita Awasthi - Bala Cynwid PA, US
John Lubinski - Malvern PA, US
International Classification:
A61K 39/245
US Classification:
4242311
Abstract:
This invention provides vaccines comprising two or more recombinant Herpes Simplex Virus (HSV) proteins selected from a gD protein, a gC protein and a gE protein; and methods of vaccinating a subject against HSV and treating, impeding, inhibiting, reducing the incidence of, or suppressing an HSV infection or a symptom or manifestation thereof, comprising administration of a vaccine of the present invention.